Literature DB >> 10673211

Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

A R Cullen1, C L Cannon, E J Mark, A A Colin.   

Abstract

We present a case of a patient with cystic fibrosis who was thought to be colonized with Mycobacterium abscessus for 13 yr prior to developing clinically apparent mycobacterial infection. However, histologic evidence indicated that invasive mycobacterial disease was present from the onset. While accepting that chronic endobronchial colonization with atypical mycobacteria may occur in patients with cystic fibrosis, the repeated isolation of mycobacteria from the sputum of these patients should alert the clinician to the possibility of indolent disease. Early consideration of treatment for this infection should occur in any patient with cystic fibrosis in whom there is an unexplained deterioration in lung function. The recent introduction of high dose ibuprofen raises concerns about its possible contribution to the progression of the infection.

Entities:  

Mesh:

Year:  2000        PMID: 10673211     DOI: 10.1164/ajrccm.161.2.9903062

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  47 in total

Review 1.  Non-tuberculous mycobacteria in cystic fibrosis.

Authors:  Uta G Hill; R Andres Floto; Charles S Haworth
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Multiple strains of non-tuberculous mycobacteria in a patient with cystic fibrosis.

Authors:  Sarah M N Brown
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

4.  Acute respiratory failure involving an R variant of Mycobacterium abscessus.

Authors:  Emilie Catherinot; Anne-Laure Roux; Edouard Macheras; Dominique Hubert; Moussa Matmar; Luc Dannhoffer; Thierry Chinet; Philippe Morand; Claire Poyart; Beate Heym; Martin Rottman; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

5.  Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Authors:  Stacey L Martiniano; Marci K Sontag; Charles L Daley; Jerry A Nick; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 6.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

Authors:  Audrey Bernut; Jean-Louis Herrmann; Karima Kissa; Jean-François Dubremetz; Jean-Louis Gaillard; Georges Lutfalla; Laurent Kremer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 8.  Is bronchoscopy an obsolete tool in cystic fibrosis? The role of bronchoscopy in cystic fibrosis and its clinical use.

Authors:  Lisa Paul
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

9.  Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Christopher J Crist; Linda Mann; Rebecca W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria.

Authors:  Toïdi Adékambi; Philippe Colson; Michel Drancourt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.